SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries
16 references·1 citing·36 second hop
A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries (2012)A systematic review of economic evaluatio…Toward a healthy and harmonious life in China : stemming the rising tide of non-communicable diseases (2011)Toward a healthy and harmonio…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…World development indicators 2007 (2007)World development indicators …Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report (2007)Using Real-World Data for Cov…Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another (2007)Transferability of economic e…Scaling up interventions for chronic disease prevention: the evidence (2007)Scaling up interventions for …Cost-Effectiveness Analysis for Priority Setting (2006)Cost-Effectiveness Analysis f…Methods to assess the costs and health effects of interventions for improving health in developing countries (2005)Methods to assess the costs a…WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty (2003)WHO Framework Convention on T…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…Pharmacoeconomic Evaluation in the Real World (1999)Pharmacoeconomic Evaluation i…Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life (1997)Modelling in Ecomomic Evaluat…Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis (1989)Methodology and overt and hid…The Measurement of Observer Agreement for Categorical Data (1977)The Measurement of Observer A…Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations (2018)Primary and secondary prevent…Regression Towards Mediocrity in Hereditary Stature. (1886)Primary, Secondary, and Meta-Analysis of Research (1976)A method for assessing the quality of a randomized control trial (1981)A Proposal for Structured Reporting of Randomized Controlled Trials (1994)The Importance of Quality of Primary Studies in Producing Unbiased Systematic Reviews (1996)Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies (2008)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation (2005)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews (2017)Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making (2018)A Coefficient of Agreement for Nominal Scales (1960)Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. (1994)Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data (1997)The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. (1998)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)RoB 2: a revised tool for assessing risk of bias in randomised trials (2019)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Population Health and Economic Growth (2008)Economic Development, Income Inequality, and Preferences for Redistribution1 (2010)Informal Institutions and Citizenship in Rural Africa (2010)Achieving health equity: from root causes to fair outcomes (2007)Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use (2007)The political origins of health inequity: prospects for change (2014)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Modeling Good Research Practices—Overview (2012)Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2013)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 1977The Measurement of Observer Agreement for Categorical Data81,000 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement63,979 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 2003WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty1,240 cited
  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 2007Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report700 cited
  • 1997Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life595 cited
  • 1989Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis338 cited
  • 2007World development indicators 2007284 cited
  • 1999Pharmacoeconomic Evaluation in the Real World246 cited
  • 2007Scaling up interventions for chronic disease prevention: the evidence237 cited
  • 2011Toward a healthy and harmonious life in China : stemming the rising tide of non-communicable diseases155 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2005
Methods to assess the costs and health effects of interventions for improving health in developing countries
142 cited
  • 2007Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another137 cited
  • 2006Cost-Effectiveness Analysis for Priority Setting97 cited
  • Cited by

    • 2018Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations62 cited